Investitionen in Aktie LB PHARMACEUTICALS INC (LBRX)

Schwach Alle Fondsgesellschaften (13F) und deren Investment in diese Aktie über die letzten 4 Quartale. Zusätzlich aktuell von 2 Mutual Funds/ETFs gehalten (N-PORT).
Aktien-Detail
Fonds2026/Q12025/Q42025/Q3
Investment ($)QoQ ($)QoQ (%)Investment ($)QoQ ($)QoQ (%)Investment ($)QoQ ($)QoQ (%)
452.460.590 $+56.811.081 $
+19,8 %
386.678.861 $+126.672.739 $
+84,5 %
132.237.745 $
Deep Track Capital, LP82.680.147 $+8.046.730 $
+10,8 %
74.633.417 $+21.692.642 $
+41,0 %
52.940.775 $
BlackRock, Inc.60.931.038 $+11.092.367 $
+22,3 %
49.838.671 $+34.443.420 $
+223,7 %
RA CAPITAL MANAGEMENT, L.P.54.464.175 $+5.300.650 $
+10,8 %
49.163.525 $+21.105.358 $
+75,2 %
28.058.167 $
TCG Crossover Management, LLC45.279.611 $+6.435.577 $
+16,6 %
38.844.034 $+11.290.231 $
+41,0 %
27.553.803 $
Commodore Capital LP36.990.000 $+3.600.000 $
+10,8 %
33.390.000 $+9.705.000 $
+41,0 %
23.685.000 $
JPMORGAN CHASE & CO35.871.589 $+19.566.788 $
+120,0 %
Caligan Partners LP34.628.726 $
Spruce Street Capital LP33.644.866 $+11.260.366 $
+50,3 %
22.384.500 $
Trails Edge Capital Partners, LP32.535.467 $+1.469.233 $
+4,7 %
31.066.234 $
Logos Global Management LP22.563.900 $-4.148.100 $
-15,5 %
26.712.000 $+8.869.300 $
+49,7 %
Nantahala Capital Management, LLC25.964.366 $+10.938.866 $
+72,8 %
VANGUARD GROUP INC24.774.891 $
BALYASNY ASSET MANAGEMENT L.P.22.778.294 $+2.815.392 $
+14,1 %
452.460.590 $+56.811.081 $
+19,8 %
386.678.861 $+126.672.739 $
+84,5 %
132.237.745 $
Erweitert ×